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Abstract: Recent efforts to comprehensively characterize great ape genetic diversity using short-read
sequencing and single-nucleotide variants have led to important discoveries related to selection within
species, demographic history, and lineage-specific traits. Structural variants (SVs), including deletions
and inversions, comprise a larger proportion of genetic differences between and within species,
making them an important yet understudied source of trait divergence. Here, we used a combination
of long-read and -range sequencing approaches to characterize the structural variant landscape of two
additional Pan troglodytes verus individuals, one of whom carries 13% admixture from Pan troglodytes
troglodytes. We performed optical mapping of both individuals followed by nanopore sequencing of
one individual. Filtering for larger variants (>10 kbp) and combined with genotyping of SVs using
short-read data from the Great Ape Genome Project, we identified 425 deletions and 59 inversions, of
which 88 and 36, respectively, were novel. Compared with gene expression in humans, we found
a significant enrichment of chimpanzee genes with differential expression in lymphoblastoid cell
lines and induced pluripotent stem cells, both within deletions and near inversion breakpoints. We
examined chromatin-conformation maps from human and chimpanzee using these same cell types
and observed alterations in genomic interactions at SV breakpoints. Finally, we focused on 56 genes
impacted by SVs in >90% of chimpanzees and absent in humans and gorillas, which may contribute
to chimpanzee-specific features. Sequencing a greater set of individuals from diverse subspecies will
be critical to establish the complete landscape of genetic variation in chimpanzees.
Keywords: structural variation; comparative genomics; chimpanzee; nanopore sequencing; optical
mapping; chromatin organization; gene regulation; natural selection
1. Introduction
Great apes have considerable phenotypic diversity despite being closely related species. For
humans and chimpanzees, with only ~5 to 9 million years of independent evolution [1,2], significant
effort has gone into understanding the underlying genetic and molecular differences contributing to
species differences, often with the primary focus on human-unique features [3]. Direct comparison of
protein-encoding genes has identified exciting candidates, but these only account for a minor proportion
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of species differences [4]. Recent analysis of Illumina short-read sequencing has allowed identification
and genotyping of single-nucleotide variants (SNVs) at the genome scale, which have been used to
address questions related to the demographic history and genetic adaptations of each species, and
lineage-specific traits [5]. Further, transcriptome and epigenome comparisons of immortalized cell
lines and tissues have revealed many thousands of individual genes and putative cis-acting regulatory
elements that contribute to species differences in gene regulation [6–13], though often with varied
results and reproducibility across studies.
Since the publication of the chimpanzee genome [14], comparison with the human reference
genome showed that structural variants (SVs), or genomic rearrangements such as inversions and
copy-number variants (deletions and duplications), comprise a greater proportion of genetic differences
than SNVs [15]. Though important, SVs are difficult to discover and genotype using traditional
short-read Sanger and Illumina data. As such, genome-wide analyses of SVs have leveraged
alternative approaches, including fosmid-end mapping [16], array comparative genomic hybridization
(CGH) [17–20], digital array CGH using whole-genome shotgun sequencing of Sanger [21] and
Illumina [22], and comparisons with improved genome assemblies [23–26]. Most recently, the advent
of long-read sequencing technologies, capable of completely traversing variant breakpoints, has
significantly facilitated discovery of novel SVs [27]. To date, only one study has performed long-read
sequencing of a chimpanzee; the most recent improvement to the chimpanzee reference genome
(panTro6) used hybrid long-read (PacBio) and long-range sequencing approaches (Bionanogenomics
(BNG) and Hi-C) of one individual, Clint, a male representing the subspecies Pan troglodytes verus,
significantly increasing the number of known SVs [26].
Recent comparisons of short- and long-read sequencing technologies using benchmark human
genomic datasets revealed that multiple genomes [28] and combinatorial platforms [29] are required
for comprehensive SV discovery; therefore, we performed long-range BNG optical mapping and
Oxford Nanopore Technologies (ONT) long-read sequencing of additional chimpanzee individuals.
These new datasets have allowed us to more comprehensively assess deletions and inversions in
the chimpanzee genome. When compared with published whole-genome screens using orthogonal
approaches, our approach validated existing variants and discovered many new variants. Knowing
that SVs often alter gene functions and regulation [20,30], we characterized the association of our
discovered SVs on differences in gene regulation and chromatin organization between human and
chimpanzee, identifying a number of events that likely contribute to chimpanzee-specific differences.
2. Methods
2.1. Cell line Growth and DNA Extraction
Chimpanzee AG18359 and S003641 lymphoblastoid cell lines (LCLs) were generously shared
with us by Dr. Yoav Gilad at the University of Chicago. LCLs were grown in T75 flasks with RPMI
1640 medium with L-Glutamine supplemented with 15% fetal bovine serum (Thermo Fisher Scientific,
Waltham, MA, USA) and Penicillin-Streptomycin (100 U/ml, VWR, Radnor, PA, USA). For Illumina
XTen sequencing, genomic DNA (gDNA) was isolated using DNeasy Blood and Tissue kit (Qiagen,
Germantown, MD, USA) followed by RNase A treatment (Roche, Mannheim, Germany) and ethanol
precipitation. For ONT PromethION sequencing, high molecular weight (HMW) gDNA was isolated
from 5 × 107 cells following a modified Sambrook and Russell method as described previously [26,31].
The integrity of the HMW DNA was verified on a Pippin Pulse gel electrophoresis system (Sage
Sciences, Beverly, MA, USA). For the BNG assay, HMW gDNA was isolated from cells using the
BNG Prep Blood and Cell Culture DNA Isolation Kit (BNG #80004). Briefly, 1.5 × 106 cells were
resuspended in Cell Buffer and embedded in an agarose plug. The plug was treated with Proteinase K
for 18 h followed by RNase A digestion for one hour. After extensive washing, the plug was melted,
agarose was digested, and drop dialysis was performed to clean the DNA. A Qubit dsDNA BR Assay
kit (Thermo Fisher Scientific) was used to quantify the DNA. All sequence data generated as part
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of this project are available for download at the European Nucleotide Archive (accession number
PRJEB36949).
2.2. Determination of Chimpanzee Subspecies
gDNA isolated from AG18359 and S003641 LCLs was sequenced at ~30× coverage with Illumina
HiSeq XTen (Novogene, Sacramento, CA, USA and the UC Davis Genome Center DNA and Expression
Analysis Core, Davis, CA, USA, respectively) and SNVs were identified following a previously published
approach [32]. Briefly, reads were mapped using BWA (v0.7.17) against the chimpanzee reference
genome (CHIMP2.1.4) using BWA-MEM with default parameters. Picard (v2.18.23) MarkDuplicates
was used to remove duplicates with the flag “REMOVE_DUPLICATES = true.” SNVs were called
using FreeBayes (v1.2.0) with the following flags: “–standard-filters –no-population-priors -p 2
–report-genotype-likelihood-max –prob-contamination 0.05.” We then filtered autosomal SNVs with
QUAL ≥ 30 and intersected with data from de Manuel et al. [32] callable genome regions, and finally
merged with the 59 genomes from de Manuel et al. [32], using bcftools merge with the following flags:
“–missing-to-ref –force-samples.” EIGENSOFT smartpca [33] was used to define principal components
(PCs) using the 59 Great Ape Genome Project (GAGP) chimpanzee genomes [32] and the genomes from
AG18359 and S003641 were projected onto these components. We estimated the variance explained
by each of the first 20 PCs as the eigenvalue/sum (top 20 eigenvalues). To expedite the analysis, it
was run on 50% of the genome-wide SNVs. Admixture analysis was performed with the software
ADMIXTURE [34] with a set the number of ancestral populations K = 4 corresponding to the four
chimpanzee subspecies.
2.3. ONT Promethion Library Preparation and Sequencing
gDNA was sheared to an average size of 50 kbp using a Megaruptor instrument (Diagenode,
Denville, NJ, USA) and then verified on a Pippin Pulse gel. A sequencing library was prepared starting
with 2 µg of sheared DNA using the ligation sequencing kit SQK-LSK109 (ONT, Oxford, UK) following
the instructions of the manufacturer with the exception of extended incubation times for DNA damage
repair, end repair, ligation, and bead elutions. Thirty femtomole of the final library was loaded on
PromethION R9.4.1 flow cell (ONT, Oxford, UK) and the data were collected for 64 h. Basecalling
was performed live on the compute module using MinKNOW v2.1 (Oxford Nanopore Technologies,
Oxford, UK). Details of the dataset can be found in Table S1.
2.4. BNG Saphyr Library Preparation and Sequencing
AG18359 and S003641 were sequenced at the McDonnell Genome Institute at Washington
University and the UC Davis Genome Center DNA and Expression Analysis Core, respectively. A
total of 750 ng of HMW gDNA was labeled with DLE-1 enzyme, followed by proteinase digestion
and a membrane clean-up step using the BNG Prep DLS DNA Labeling Kit (#80005). After overnight
staining with an intercalating dye, the labeled DNA was loaded onto a Saphyr Chip G2.3 (BNG #20366)
and run on the Saphyr system (BNG #60325) using the Saphyr Instrument Control Software (ICS,
version 3.1) to maximize throughput of molecules. Raw images of DNA were converted into digital
molecules files using Saphyr ICS version 3.1. Details of both datasets can be found in Table S1.
2.5. Detection of SVs
To detect SVs, ONT long-reads were mapped to the human (GRCh38, no alternative haplotypes)
and the chimpanzee reference genome (panTro6) using minimap2 (v2.17-r941) and SVs were identified
using Sniffles (v1.0.11) with “–genotype” flag and default parameters. Large SVs were identified
from BNG opticals maps using Bionano Solve (v3.5) [35] de novo genome assembly and SV-discovery
pipeline using human GRCh38 as the reference. The SV file in SMAP format was converted to VCF
format using the smap_to_vcf_v2.py script contained in Solve software (v3.4.1). Only the variants with
“PASS” filter were considered in the analysis and homozygous reference calls were removed. SV size
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selection and filtering were performed with the bcftools (v1.9) view using the filter “INFO/SVLEN ≥
10,000 || INFO/SVLEN < −10,000” for both ONT and BNG datasets. To compare overlap between the
SVs discovered by each method, we obtained 50% reciprocal overlap between features using bedtools
intersect (v2.29.0) with flags “−f 0.5 −F 0.5.” Deletions and inversions were retrieved from the SVTYPE
tag and processed separately in downstream analyses.
2.6. Genotyping and Filtering of SVs
Variants for each callset were genotyped independently using previously published Illumina
data from 25 chimpanzees from all four subspecies, as well as eight gorillas and eight humans. SNV
genotypes from non-human primates were retrieved from the GAGP [5] and human SNV genotypes
were obtained from the Simons Genome Diversity Project [36] (Table S2). Reads were mapped to the
human reference (GRCh38) using BWA MEM (0.7.17−r1188) [37] and subsequently merged and sorted
with samtools (v1.9) for each individual. Large inversions and deletions (>10 kbp) were genotyped with
SVtyper (v.0.7.1) [38]. Genotype information was retrieved using bedtools query (v2.29.0). To assess
whether a variant was novel to this study, calls were compared to previously reported deletions and
inversions larger than 10 kbp found in any great ape or any variant discovered in chimpanzee [22,23,26]
using bedtools intersect (v2.29.0) with 50% reciprocal overlap. SVs that were either (1) genotyped
in one chimpanzee individual (1/1 or 0/1) or (2) reported as discovered in chimpanzee in previous
studies, were selected to generate a higher confidence set (filter 1). This dataset was further refined by
collapsing calls within the dataset with 50% reciprocal overlap. All novel calls were visually inspected
in Integrative Genome Browser for ONT calls [39] and Bionano Access for BNG calls. Also, SVs present
in ≥90% of the chimpanzee individuals (22 or more) as well as absent in outgroups (human and gorilla)
were included in the likely chimpanzee-specific dataset (filter 2). In Kronenberg et al. [26], eight
chimpanzee individuals were genotyped; as such, variants with evidence in seven or more individuals
were also included in the chimpanzee-specific dataset. The distribution of high-confidence calls across
the human reference (GRCh38) was plotted using the R package Karyoplotter [40].
2.7. Annotation of Impacted Genes
Genes impacted by SVs were obtained by intersecting Gencode v27 genomics features annotation
file to deletion coordinates ±2.5 kbp and inversion breakpoints (considered as estimated breakpoints
±2.5 kbp and ±50 kbp) using bedtools intersect (v2.29.0). The impact of the SVs on the function of
the gene was predicted using Ensembl Variant Effect Predictor (VEP) [41] with the Gencode v27 GTF
file. The probability of loss of function intolerance score (pLI) was obtained from the gene constraints
scores table in the Exome Aggregation Consortium database [42]. Gene ontology (GO) annotations
and overrepresented terms were retrieved for each gene using DAVID [43,44] and by selecting terms at
a 5% false-discovery rate (FDR). Genes previously identified as showing signatures of positive and
balancing selection in chimpanzees were retrieved from previously published data [45], and intersected
with the set of genes impacted by SVs.
2.8. Differential Gene Expression
We obtained previously-published RNA-seq data from chimpanzee and human LCLs [7] and
induced pluripotent stem cells (iPSCs) [46]. Raw data were trimmed using TrimGalore (v0.6.0)
with the following parameters: “-q 20 –phred33 –length 20”. Transcripts per million (TPM) values
were estimated using Salmon (v0.14.1) [47] with the “–validateMappings” flag for all transcripts in
GENCODE v27 and chimpanzee transcriptome published by Kronenberg et al. (2018) [26], which
was based on a combination of orthologous genes identified via comparisons of human GENCODE
v27 and novel transcripts identified through PacBio isoSeq of iPSCs. The R package tximport [48]
was used to estimate gene-level counts from TPM values using the setting ‘countsFromAbundance =
“lengthScaledTPM”’ for 55,461 annotated genes with equivalent identifiers in the two transcriptomes.
Differential expression analysis was conducted with limma-voom [49,50]. Genes with fewer than 1
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count per million across all samples were filtered from the analysis, and a model accounting for species
and sex was implemented. Differentially-expressed (DE) genes were called at a 5% FDR.
2.9. Topologically-Associated Domain (TAD) Analyses
We retrieved published TAD predictions from an LCL of a human female (GM12878) originally
called with 4.9 billion Illumina reads [51]. Domain coordinates were transformed from GRCh37
to GRCh38 using liftOver (UCSC Genome Browser; 9262/9274 domains successfully converted).
Boundaries were defined as the start and end coordinates of each domain expanded to 5 kbp (resolution
size of the TAD-calling analysis).
To directly compare domain boundaries between humans and chimpanzees, we generated DNase
Hi-C libraries from three human (GM12878, GM20818, GM20543) and two chimpanzee (S007602,
AG18359) LCLs as described by Ramani et al. [52]. Raw data were processed using the Juicer pipeline [53]
with the human reference GRCh38. Human alignments were downsampled to ~300 million reads
to allow for equal comparison to chimpanzee, and Hi-C interaction matrices were generated with a
(BWA) MAPQ filter of 30. Domains were called on Knight-Ruiz normalized contact matrices using
TopDom [54] at 50 kbp resolution and the default window size (w = 5). Similarity between domain
sets was computed with the Measure of Concordance (MoC) as implemented previously [55] using
chromosome 1. Domain calls were visualized with interaction maps (coverage normalized at 5 kbp
resolution) using Juicebox (1.11.08). Across all chromosomes, boundaries unique to each species were
considered to be the left and right coordinates of each domain, expanded to 50 kbp, when that region
was not adjacent to (or overlapping) a boundary from the other species. This analysis was repeated
using high-depth raw Hi-C data from four human and four chimpanzee iPSCs with approximately 1
billion reads per sample (combined across individuals; also normalized by downsampling) [12].
2.10. Permutation Analyses
For each variant, the distance to the nearest segmental duplication (SD; duplicated region with
>90% identity across >1 kbp, downloaded from UCSC Genome Browser GRCh38) was calculated using
bedtools closest (v2.29.0). Regions of the same size (deletions ±2.5 kbp and inversions ±2.5 kbp) were
randomly sampled from the human genome using bedtools shuffle (v2.29.0), and 5-kbp “breakpoints”
were extracted from shuffled inversions. The distribution of the distance of these random regions to
the nearest SD was plotted as density using the R package ggplot2. Permutation tests to assess the
enrichment/depletion of genomic features (e.g., genes, boundaries) at SVs were similarly performed by
shuffling the SV coordinates 1000 times and counting the number of intersecting features with each set
of coordinates. SVs were tested for enrichment of DE genes by generating 1000 random samples of
all genes tested in the expression analysis of equal size to the differential set. One-tailed empirical
p-values were calculated as follows: p-value = (M + 1)/(N + 1), where M is the number of iterations
yielding a number of features less than (depletion) or greater than (enriched) observed and N is the
number of iterations.
3. Results
3.1. Large-Scale SV Discovery and Genotyping in Chimpanzee
To date, one western chimpanzee individual (Clint) comprising the reference genome (panTro6)
has been subject to hybrid long-read sequencing for genome assembly and SV discovery [26]. We
sought to expand SV discovery via long-read sequencing to two additional chimpanzee individuals
(AG18359 and S003641) for which renewable LCLs and functional genomic information, including
RNA-Seq and ChIP-Seq data [7,13,56], are available. To begin, we performed Illumina short-read
sequencing (~30× coverage) of both individuals to confirm ancestry via SNV detection followed by
comparisons of population-specific genetic markers and PC analysis with chimpanzees from the
GAGP [5] (Figure S1). From this, we determined AG18359 to be a female western chimpanzee (Pan
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troglodytes verus) and S003641 to be a male western chimpanzee with some central chimpanzee ancestry
(Pan troglodytes verus × Pan troglodytes troglodytes). Notably, ~13% of the ancestry of this individual is
assigned to the central-chimpanzee population, similar to one individual (Donald) that was sequenced
as part of the GAGP.
To discover potentially novel chimpanzee SVs, we assayed AG18359 gDNA using ONT
PromethION (29×) and BNG optical mapping (116×) (Table S1). To compare SV discovery of
two individuals on the same platform, we also subjected S003641 to BNG optical mapping (70×). As
it is the most accurate and well-annotated primate assembly, we mapped our sequence data to the
human reference genome (GRCh38). We excluded SDs and insertions from our analysis of SVs due to
challenges in their discovery and validation [57]. Focusing exclusively on deletions and inversions,
we discovered 49,579 deletions and 560 inversions using ONT and 4790 deletions and 280 inversions
using BNG from AG18359. Similarly, we identified 5407 deletions and 207 inversions using BNG
from S003641. For comparative purposes, we also mapped the AG18359 ONT sequence data to the
most recent chimpanzee reference genome (panTro6) and discovered fewer events (7895 deletions and
142 inversions) suggesting that a significant proportion of SVs identified via mapping to the human
reference represented species differences.
As the primary goal of our study was to identify species differences, we moved forward with
SVs identified using the human reference genome. We next compared SV discovery across our
two platforms. Although ONT had higher sensitivity to discover smaller variants, down to 50 bp,
there was a higher chance of detecting false positives and errors at this resolution (Figure S2A). To
properly compare across technologies, we filtered for large SVs (≥10 kbp) and compared similarities
by consolidating variants with more than 50% reciprocal overlap. We found a comparable number
of deletions in our three call set (586, 586, and 666 events in AG18359 ONT, AG18359 BNG, and
S003641 BNG, respectively) with 138 deletions found by all three call sets (Table S3, Figure S2B). Out
of the 586 deletions found in the AG18359 ONT call set, 381 were uniquely discovered using this
technology, while BNG contributed another 553 deletions, out of which 307 (55.5%) had support from
both individuals. As such, deletion call sets from the same technology exhibited a greater overlap
than comparing calls from different technologies of the same individual. We also found a comparable
number of inversions across all three call sets (243, 269, and 207 variants in AG18359 ONT, AG18359
BNG, and S003641 BNG, respectively) (Figure S2B), of which 34 variants were shared among them all.
Again, the most overlap for inversions was identified between different individuals assayed using the
same BNG technology, representing 80 shared out of the total 274 unique variants.
In order to narrow in on a higher-confidence set of SVs, we subsequently performed genotyping of
this discovery set using short-read Illumina data from GAGP (>20-fold coverage) of all four chimpanzee
subspecies (n = 25) (Table S2) using SVTyper [38]. We also compared our discovered SVs with
previously-reported datasets from three recent whole-genome SV screens of chimpanzees [22,23,26],
each using diverse genomic methods for discovery (Tables S5 and S6). From this, we identified
425 deletions and 59 inversions that had support from short-read genotyping and/or intersecting
with a previously-discovered SV (Tables S7 and S8). In all, our discovery approach using ONT and
BNG data achieved 88 novel deletions and 36 novel inversions when compared with the most recent
genome-assembly alignment [23,26] and read-depth [22] approaches (Figure 1A,B).
3.2. Genomic Features of Identified SVs
Examining genomic features of our high-confidence set of chimpanzee SVs, we found that deletion
sizes ranged between 10 kbp (our minimum threshold) up to ~526 kbp (31 kbp mean; 18.5 kbp median)
(Figure 1C) and inversions ranged in size between 10 kbp and 78 Mbp (4.1 Mbp mean; 57.3 kbp median),
including four of seven known chimpanzee pericentric inversions identified only with ONT (n = 2)
or with both technologies (n = 2) [58–64]. The majority of novel inversions identified in our study
tended to be smaller (57 kbp mean length), perhaps influenced by strict size cutoffs (>100 kbp) used in
previous studies [23]. The distribution of SVs across the human genome (Figure 1A and Figure S3) was
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relatively uniform for deletions, which were found on all 24 chromosomes. The greatest number of
events were identified in chromosome 2 (n = 34); however, when normalizing by the total number of
bases, chromosomes 19 (0.34 deletions per Mbp) and 21 (0.32 deletions per Mbp) exhibited the highest
number of deletions (Figure S3). Inversions, on the other hand, were found on 19 chromosomes,
with chromosome 5 exhibiting the greatest number of variants (n = 8), and chromosomes 5, 7 and 12
displaying the greatest number of inversions per chromosome size (0.04 inversions per Mb). Further,
we found that SV breakpoints of both deletions and inversions were non-randomly distributed across
the human genome near SDs (Figure 1D, empirical p-value = 1 × 10−4), similar to previously reported
results for distribution of SDs in primate genomes [21,22,65,66]. This observed clustering may be
accounted for by SD-mediated deletions and inversions that can be created via non-allelic homologous
recombination [67].
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and S10). Deletions overlapped ith 592 genes, out of hich 162 were protein-encoding genes
(Figure 2A). To further refine the impact of SVs and gene function, e focused on protein-encoding
genes and used Ensembl Variant Effect Predictor (VEP) to predict functional impact. VEP annotated 80
protein-encoding genes as highly impacted by deletions (i.e., feature ablation or truncation), out of
which 54 have been previously classified as loss of function (LoF) tolerant (pLI ≤ 0.1) by the Exome
Aggregation Consortium [68,69] (Figure 2B). Also, three genes (ATXN2L, SH2B1, and IL27), which all
reside within the same ~500 kbp “deletion” mapped to human chromosome 16p11.2, were classified as
LoF intolerant (pLI ≥ 0.9). A search through the chimpanzee reference (panTro6) found ATXN21 and
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SH2B1 residing on an uncharacterized chimpanzee chromosome Un_NW_019937196v1, suggesting
that these genes have been translocated to a new genomic locus. This is likely the case for other genes
with predicted high-variant effect and LoF intolerance. Focusing on inversions, we found breakpoints
overlapping with 342 transcribed elements of which 64 genes were within 2.5 kbp of breakpoints,
including 95 and 21 protein-encoding genes, respectively (Figure 2A). No highly impacted genes, as
predicted by VEP, were found in this dataset. Using pLI scores, we identified 9 genes either modified
or overlapped by inversions classified as loss-of-function intolerant in humans (Figure 2B).
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Figure 2. Description of genes overlapping identified SVs. (A) Categories of genes overlapping deletion
regions ±2.5 kbp and inversion breakpoints ±50 kbp as defined by ENSEMBL biotypes. (B) Number of
protein-encoding genes classified as LoF tolerant (pLI ≤ 0.1), intolerant (pLI ≥ 0.9) and middle range
(pLI > 0.1 and pLI < 0.9) affected by deletions regions ±2.5 kbp and inversion breakpoints ±50 kbp.
Some affected genes lack LoF information (missing category). All genes impacted by deletions were
classified by VEP as either highly impacted (feature ablation or truncation) or modified, while genes
impacted by inversions were either modified or no effect was predicted (overlap only). Transcribed
elements with no corresponding ENSEMBL transcript ID in humans were classified as no orthology
(blue). (C) Overrepresented GO terms in genes impacted by deletions and inversions as reported by
DAVID (* q-value < 0.05; ** q-value < 0.001). Counts represent the number of genes annotated with
each GO term.
In total, we found a significant depletion of protein-encoding genes at deletion regions (162 genes
within 2.5 kbp, empirical p-value = 0.001, Figure 3 and Figure S4A) as well as at inversion breakpoints
(21 protein-encoding genes within 2.5 kbp, empirical p-value = 0.001, Figure 3 and Figure S4B). Notably,
this depletion did not persist when considering all transcribed elements intersecting SVs. Taking a
closer look at genes with clear orthologs between chimpanzee and humans, we identified significantly
fewer orthologs of deletion-impacted genes vs. inversion-i pacte genes (67% vs. 89%, respectively;
p-value = 1 × 10−5 Fisher’s exact test). The majority of deletion-impacted genes with no orthologs
were predicted to have high-VEP effect (179 out of 195 genes), suggesting that deletion of these genes
completely ablated them from the chimpanzee genome.
Finally, we explored functional annotations of genes impacted by SVs. We found 208 transcribed
elements impacted by deletions with known GO annotations as reported by DAVID [43,44] (Figure 2C).
Compared to the complete set of human GO annotations, this gene list displays an overrepresentation of
genes associated with sensory perception of smell (GO: 0050911, q-value = 8.7 × 10−11 and GO:0007608,
q-value = 3.3 × 10−2). We also found an overrepresentation of deletion-impacted genes involved
in the G-protein coupled receptor signaling pathway (GO: 0007186, q-value = 5 × 10−5). Notably,
both ontologies are primarily driven by known copy-number polymorphism that exists among
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olfactory-receptor genes [70]. Inversions contained 140 genes with known GO functional annotation
exhibiting an overrepresentation of regulation of cell differentiation (GO: 0045596, q-value = 1.2 × 10−4).
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3.4. SVs and Gene Regulation
To understand if variants might affect gene regulation, we leveraged existing RNA-seq datasets
generated from chimpanzee and human LCLs [7] and iPSCs [46]. From 55,461 human–chimpanzee
orthologous transcribed features, we identified 6565 and 8946 genes in LCLs and iPSCs, respectively,
as significantly DE between the two species (Tables S11 and S12). Among genes for which
human-chimpanzee orthology was assigned that directly intersected SVs (N = 397 in deletions
±2.5 kb; N = 61 for inversion breakpoints ±2.5 kb), roughly half were significantly DE (57/135 LCL and
60/129 iPSC tested genes in deletions; 25/37 LCL and 22/36 iPSC tested genes in inversion breakpoints)
(Tables S9 and S10). We report a significant enrichment of DE genes from both cell types within (±2.5
kb; permutation test empirical p-value < 0.04) and near (±50 kb; p-value < 0.01) deletions and near
(±50 kbp; p-value < 0.002) inversion breakpoints. DE gene enrichment was only significant within
(±2.5 kbp) inversion breakpoints in LCLs Figure 3 and Figure S4).
Considering that gene regulation may be affected by changes in genome organization, we next
assayed the impact of SVs on chromatin structure by intersecting with previously identified TADs
from a deeply-sequenced human LCL (GM12878) [51] and found 45 and 17 TAD boundaries likely
disrupted by deletions and inversions, respectively, in chimpanzees. Similar to what others have
reported [71,72], deletions were less likely than expected by chance to straddle TAD boundaries,
thereby generating putatively disrupted TADs (PDTs) (permutation test empirical p-value < 0.01 within
2.5 kbp and 50 kbp of deletions; Figure 3 and Figure S4A). This is consistent with the hypothesis that
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regions maintaining chromatin structure are subject to negative selection. Not previously reported,
we also found a significant depletion of PDTs intersecting inversions (p-value = 0.001 within 2.5 kbp
and 50 kbp of inversions; Figure S4B). Within PDTs we identified 58 and 65 DE genes in LCLs and
iPSCs, respectively. This suggests that disruption of genome organization may have contributed to
interspecies changes in gene expression for a subset of genes. Example loci are highlighted in Figure 4A,
Figure S5, S7 and S8. Notably, chromatin structure was also apparently altered by variants near but not
directly intersecting identified TAD boundaries (Figure 4B and Figure S6).
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noting differences at SVs (dotted boxes) including deletions and inversions. SDs are depicted as colored
bars, taken from the UCSC Genome Browser track. Genes showing significant DE in chimpanzee versus
humans are colored as red (up in chimpanzee) or blue (down in chimpanzee). Genes not included in
the DE analysis are in gray (Tables S11 and S12).
To examine chromatin structure of PDTs, we generated orthologous Hi-C maps from human
and chimpanzee LCLs and iPSCs [12] against the human reference (GRCh38) and directly compared
differences in domain boundaries between species. Overall, domain calls were similar between species
(MoC 0.75 and 0.79 for LCLs and iPSCs, respectively [55]). We examined chimpanzee PDTs and
identified more chimpanzee-unique boundaries than genome-wide boundaries (30.5% (18/59) versus
24.9% (1424/5714)). Similarly, for iPSCs we found 22.0% (13/59) of boundaries in PDTs were not shared
with human, compared to 14.9% genome-wide boundaries (868/5834). These numbers suggest that
TAD-altering SVs may impact chromatin structure in chimpanzees.
Closer inspection of these regions revealed examples of altered gene expression coinciding with
changes to three-dimensional chromatin structure. For example, the breakpoints of an inversion
mapping to human chromosome 2q12.2-13 lie near altered domain boundaries and DE genes in
iPSCs. Both UXS1 and SH3RF3 reside in altered domains and show increased contact frequency with
chimpanzee-proximal inverted sequences that are over 1 Mbp away in the human genome (Figure 4A
and Figure S5A). Similar gains of interactions are visible in the LCL Hi-C data with UXS1 also DE,
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though in the opposite direction (Figure S5B). A smaller inversion mapping to human chromosome
9q22.31 appears to mediate a domain fusion in both iPSCs and LCLs (Figure 4B and Figure S6). In both
cell types, the nearby (<8 kbp away) gene SPTLC1 and truncated processed pseudogene AL136097.2
are upregulated and downregulated, respectively, in chimpanzees compared with humans (Figure 4B
and Figure S6). Other examples of domain-altering deletions and nearby DE genes are presented in
Figures S7 and S8. Altogether, these data provide evidence that SVs may drive DE patterns, either
through disruption of the transcribed sequence itself or through altered cis-acting regulation, mediated
by reorganization of physical interactions within chromatin.
3.5. Genes Showing Signatures of Natural Selection
Recent efforts to sequence diverse great ape genomes have led to identification of signatures of
natural selection using SNV data that may help to explain features unique to chimpanzee species and
subspecies [5,32,45,73]. To understand if our identified SVs might impact the outcome of such studies
or explain signatures of selection previously identified, we compared our map of SVs with a recent
study of natural selection in multiple genomes of the four chimpanzee subspecies (Pan troglodytes
verus, troglodytes, ellioti, and schweinfurthii) mapped to the human reference genome [45]. In this study,
among several other tests, the Hudson–Kreitman–Aguade (HKA) test [74] was used to identify the top
200 genes showing the strongest signatures of long-term balancing selection and positive selection in
each subspecies. Intersecting this set of genes with our complete list of genes residing within or near
deletions (Table S9), we determined that of the 592 genes putatively disrupted by a deletion, 54 show
strong signatures of natural selection using the HKA test (32 for positive and 22 for balancing selection).
For inversions, of the 342 genes at or near inversion breakpoints, six show strong signatures of natural
selection (five for positive, one for balancing) (Table S10). Of all the genes affected by SVs and with
strong signatures of natural selection, nine have evidence of DE in either LCLs or iPSCs, including two
protein-encoding genes showing signatures of balancing selection: INPP4B, which carries a deletion
upstream of the transcription-start site and is upregulated in chimpanzee LCLs, and HLA-F, which
is completely deleted and is upregulated in chimpanzee LCLs and downregulated in iPSCs. The
possibility that these deletions generated beneficial expression changes that became strongly affected
by natural selection makes these genes interesting candidates for follow up.
3.6. Genes Impacted by Chimpanzee-Specific SVs
To hone in on SVs unique and universal to chimpanzees that may contribute to species-specific
features, we consolidated the complete dataset of our newly discovered SVs and those previously
published [22,23,26]. Filtering for only those with positive genotypes in >90% of chimpanzee individuals
genotyped but found in neither humans (n = 8) nor gorillas (n = 8), we identified 209 deletions and
18 inversions. This set ranged in size from 10 kbp to 526 kbp for deletions and 12 kbp to 78 Mbp for
inversions (including the four large-scale cytogenetic events). Again due to the olfactory receptors
at these loci, GO analysis shows that the genes contained within these SVs were overrepresented
for the detection of chemical stimulus involved in sensory perception of smell (GO:0050911, q-value
4.1 × 10−2). Focusing on genes with a higher likelihood of being functionally impacted by SVs, we
identified 56 protein-encoding genes with a high-impact VEP score (deletions) or within 2.5 kbp of a
breakpoint (inversions) (Table 1). Of the 35 genes queried in our cross-species RNA-seq comparisons,
13 exhibited significant DE in chimpanzee versus human in LCLs and/or iPSCs, including APOL4,
CAST, CLN3, EFCAB13, EIF3C, IL18R1, NPIPB8, NPIPB9, NUPR1, RABEP2, SGF29, SLC01B3, and
SULT1A1. Additionally, six genes showed strong signatures of positive selection (APOBR, IL27, and
TUFM at human chromosome 16p11.2 and OR10H1 and OR10H5 at human chromosome 19p13.12) or
balancing selection (CLC at human chromosome 19q13.2). In all, this list of genes represents exciting
candidates putatively implicated in chimpanzee-specific traits.
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Table 1. Protein-encoding genes impacted by chimpanzee-specific deletions and inversions.
Gene ENSEMBL ID SV Type Description
APOBR ENSG00000184730 deletion Apolipoprotein B receptor
APOL1 ENSG00000100342 deletion Apolipoprotein L1
APOL4 * ENSG00000100336 deletion Apolipoprotein L4
ATP2A1 ENSG00000196296 deletion Sarcoplasmic/endoplasmic reticulum calcium ATPase 1
ATXN2L ENSG00000168488 deletion Ataxin 2 like
CARD18 ENSG00000255501 deletion Caspase recruitment domain family member 18
CAST * ENSG00000153113 inversion Calpastatin
CD19 ENSG00000177455 deletion CD19 Molecule
CEACAM21 ENSG00000007129 deletion CEA Cell Adhesion Molecule 21
CFHR2 ENSG00000080910 deletion Complement Factor H Related 2
CFHR4 ENSG00000134365 deletion Complement Factor H Related 4
CLC ENSG00000105205 deletion Charcot-Leyden crystal Galectin
CLN3 * ENSG00000188603 deletion CLN3 Lysosomal/Endosomal Transmembrane Protein, Battenin
CMPK1 ENSG00000162368 deletion Cytidine/Uridine Monophosphate Kinase 1
CROCC ENSG00000058453 inversion Ciliary Rootlet Coiled-Coil, Rootletin
CYP2C18 ENSG00000108242 deletion Cytochrome P450 Family 2 Subfamily C Member 18
DEFB128 ENSG00000185982 deletion Defensin Beta 128
EFCAB13 * ENSG00000178852 deletion EF-Hand Calcium Binding Domain 13
EIF3C * ENSG00000184110 deletion Eukaryotic Translation Initiation Factor 3 Subunit C
IL18R1 * ENSG00000115604 inversion Interleukin 18 Receptor 1
IL1RL1 ENSG00000115602 inversion Interleukin 1 Receptor Like 1
IL27 ENSG00000197272 deletion Interleukin 27
IL36B ENSG00000136696 deletion Interleukin 36B
IL37 ENSG00000125571 deletion Interleukin 37
KRTAP19-6 ENSG00000186925 deletion Keratin Associated Protein 19-6
KRTAP19-7 ENSG00000244362 deletion Keratin Associated Protein 19-7
LCN10 ENSG00000187922 deletion Lipocalin 10
LCN6 ENSG00000267206 deletion Lipocalin 6
LGALS14 ENSG00000006659 deletion Galectin 14
MERTK ENSG00000153208 deletion MER Proto-Oncogene, Tyrosine Kinase
NPIPB8 * ENSG00000255524 deletion Nuclear Pore Complex Interacting Protein Family Member B8
NPIPB9 * ENSG00000196993 deletion Nuclear Pore Complex Interacting Protein Family Member B9
NUPR1 * ENSG00000176046 deletion Nuclear Protein 1, Transcriptional Regulator
OBP2A ENSG00000122136 deletion Odorant Binding Protein 2A
OR10H1 ENSG00000186723 deletion Olfactory Receptor Family 10 Subfamily H Member 1
OR10H5 ENSG00000172519 deletion Olfactory Receptor Family 10 Subfamily H Member 5
OR2T33 ENSG00000177212 deletion Olfactory Receptor Family 2 Subfamily T Member 33
OR6C2 ENSG00000179695 deletion Olfactory Receptor Family 6 Subfamily C Member 2
OR6C3 ENSG00000205329 deletion Olfactory Receptor Family 6 Subfamily C Member 3
OR6C65 ENSG00000205328 deletion Olfactory Receptor Family 6 Subfamily C Member 65
OR6C70 ENSG00000184954 deletion Olfactory Receptor Family 6 Subfamily C Member 70
OR6C75 ENSG00000187857 deletion Olfactory Receptor Family 6 Subfamily C Member 75
OR6C76 ENSG00000185821 deletion Olfactory Receptor Family 6 Subfamily C Member 76
POU6F2 ENSG00000106536 deletion POU Class 6 Homeobox 2
RABEP2 * ENSG00000177548 deletion Rabaptin, RAB GTPase Binding Effector Protein 2
RACK1 ENSG00000204628 inversion Receptor For Activated C Kinase 1
SGF29 * ENSG00000176476 deletion SAGA Complex Associated Factor 29
SH2B1 ENSG00000178188 deletion SH2B Adaptor Protein 1
SLC35G4 ENSG00000236396 deletion Solute Carrier Family 35 Member G4
SLCO1B3 * ENSG00000111700 inversion Solute Carrier Organic Anion Transporter Family Member 1B3
SULT1A1 * ENSG00000196502 deletion Sulfotransferase Family 1A Member 1
SULT1A2 ENSG00000197165 deletion Sulfotransferase Family 1A Member 2
TUFM ENSG00000178952 deletion Tumor Protein P53
YAE1D1 ENSG00000241127 deletion YAE1 Maturation Factor Of ABCE1
AC011604.2 ENSG00000257046 inversion Uncharacterized
AL355987.1 ENSG00000204003 deletion Uncharacterized
* Human and chimpanzee orthologs were tested and shown to be significant DE genes in either LCLs and/or iPSCs;
Genes in bold were found to have strong signatures of positive or balancing selection using the HKA test [45].
4. Discussion
Most extensive SV analyses using comparative genomic approaches have used a single genome
from one chimpanzee individual of the subspecies Pan troglodytes verus (i.e., Clint) [14,16,21,23,24,26].
Here, we performed long-read sequencing of two additional individuals of the same subspecies, one of
which carried admixture with Pan troglodytes troglodytes, using two orthogonal technologies: optical
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mapping and nanopore sequencing. To our knowledge, this represents the first nanopore sequence of a
chimpanzee genome. From this, we discovered over 60,000 deletions and over 500 inversions (≥50 bp)
when compared with the human reference (GRCh38), on the same scale as found in a recent comparison
of the new chimpanzee assembly using a hybrid assembly approach (panTro6) [26]. As expected, ONT
sequencing was capable of detecting significantly more SVs, down to 50 bp with higher resolution at
breakpoints (Figure S2A), compared to our BNG datasets. Many of the bioinformatically-identified
SVs were redundant within and across technologies, which required additional filtering. To determine
a higher-confidence set of SVs, we limited our analysis to variants ≥10 kbp in size with short-read
Illumina sequencing evidence of the variant using SVtyper, a genotyping approach. Though the
genotyping step significantly increased our confidence in variant calls, it also reduced the number of
variants we identified (from 1838 to 858 deletions and from 719 to 253 inversions), particularly for
inversions, which are difficult to detect/genotype using short-read data. Additionally, our strict size
cutoff limited our ability to discover transposable elements, which has been shown to represent a
significant proportion of lineage divergence between chimpanzees and humans [75]. Furthermore,
due to the uncertainty of the BNG breakpoints, most SVs discovered using only this approach were
largely filtered from our subsequent analyses due to an inability to accurately genotype events.
Nevertheless, our approach led to the discovery of 88 novel deletions and 36 novel inversions when
compared to recent genome-wide scans. We note that we also excluded SDs and insertions from
our analysis due to difficulties in discovery and subsequent validations using standard short-read
genotyping approaches [76]. As improved hybrid-based methods combining long- and short-read data
are developed to more accurately identify SVs and their breakpoints, it will be a worthwhile endeavor
to return to our dataset to discover additional SVs.
Our results implicated chimpanzee SVs in potentially impacting gene regulation and chromatin
organization. It has been established that TAD structures are evolutionarily conserved [51,77], and recent
work finds that deletions altering TAD boundaries in humans are under purifying selection [71,72].
TAD structure is also conserved across apes, as evidenced by the incidence of gibbon–human synteny
breaks at domain boundaries [78]. Similarly, we find a depletion of PDTs generated by deletions in
chimpanzees, as well as an expected but previously unreported reduction of inversions altering TADs.
Taken together, the paucity of SVs altering domain boundaries suggests such variants in chimpanzee
experience strong negative selection, as observed in other species, perhaps due to conserved roles of
TADs in modulating gene regulation. Despite the overall depletion of SVs at TAD boundaries, we did
find an increased incidence of species-specific domain boundaries and significant enrichment of DE
genes near SVs in the two cell types queried in this study, concordant with previous findings assessing
the impact of deletions and duplications on differential gene expression in primate LCLs [20]. Our
analyses are subject to some limitations. Domain calling is highly sensitive to input parameters, but the
pairs of Hi-C maps were subject to the same analysis and highly correlated at a variety of resolutions
tested (MoC > 0.7 at 100 kbp, 50 kbp, 25 kbp, and 10 kbp for iPSCs; 100 kbp and 50 kbp for LCLs)
allowing for an assessment of genome-wide domain differences. Though the number of aligned reads
were normalized to comparable levels, relative read depth is likely to vary across the genome due to
differences in mappability. This is particularly likely at SV loci, where deletions and SDs generate
discontinuities in the Hi-C matrix. As such, these domain calls should be interpreted primarily as a
means of identifying regions of putatively disrupted chromatin structure.
Notably, many of the genes near SVs were not DE; however, it is plausible that these non-DE
genes either remain connected to their regulatory elements or their associated elements are specific to
cell types not assayed. Further, while it has been reported that topology-altering SVs can have little
effect on gene expression [79], or that expression is not globally altered by loss of TADs [80], it could
still be the case that expression-altering SVs are frequently subject to negative selection. For instance,
TAD- and expression-altering SVs reported in humans are typically de novo and pathogenic [81,82].
Regardless, our findings are concordant with those of Kronenberg et al. (2018) [26], who reported an
enrichment of human–chimpanzee cortical organoid DE genes near fixed human-specific SVs. While
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they find an enrichment for downregulated genes at insertions and deletions and upregulated genes
at SDs, their analysis produced a much smaller set of DE genes (785 across both cell types using
single-cell RNA-seq) and a much larger set of variants (17,789). These findings are also in line with
reports that SVs underlie many human expression quantitative trait loci [83]. However, considering the
currently incomplete understanding of the relationship between gene regulation and three-dimensional
chromatin structure, we emphasize that functional studies are necessary to causally implicate SVs in
gene expression differences within or between species.
In addition to using Illumina genotyping of our identified SVs to filter out putatively false
positive variants, we also used this information to query SV differences across subspecies. In our
high-confidence set of SVs, we identified one novel deletion in chimpanzees (human chromosome 6q11.1;
chr6:60639753-60662981, GRCh38) from our BNG data of the western individual carrying substantial
central ancestry (S003641) that was also found uniquely in central chimpanzees (n = 4). Considering the
relatively low ancestry contribution of this individual assigned to the central-chimpanzee population
(~13%), this highlights the importance of sequencing more diverse individuals to identify additional
subspecies-specific SVs to better survey the complete variant landscape. Using these same genotypes,
we also focused on a set of genes universally impacted by SVs across all chimpanzees tested, but
not detected in the other great apes studied (humans and gorillas), since these genes may putatively
contribute to species-specific traits (Table 1). One example, APOL4, encoding Apolipoprotein L4,
was completely deleted in all chimpanzees tested (n = 25) and also shown to be downregulated
in both LCLs and iPSCs in chimpanzees when compared with humans. This gene is a member of
a tandemly-duplicated family that has experienced a recent expansion in the primate lineage [84]
and may play a role in lipid trafficking throughout the body. Human polymorphism at this locus
has been shown to be associated with schizophrenia [85]. Several identified genes also exhibited
signatures of natural selection. One example region putatively under balancing selection includes two
deletions impacting the primate-expanded galectin gene cluster, a family of proteins that specifically
bind β-galactoside sugars and are important in modulating immune response through interactions
with T cells [86]. Both deletions (10 kbp and 35 kbp in size, respectively) are found homozygously
in all chimpanzees tested (n = 25), and thus are likely not the target of balancing selection, but they
completely ablated CLC (or LGALS10) and LGALS14, as well as the downstream region of LGALS13
(Figure S9). Two of these genes (LGALS13 and 14), expressed exclusively in human placenta [87], are
important drivers of maternal adaptive immune response, with reductions in expression of either gene
shown to be associated with an increased risk of preeclampsia [88]. Although the mechanisms are
unclear, it is notable that other immune-related genes with connections to preeclampsia also exhibit
signatures of balancing selection in humans [89–91]. It is possible that deletions impacting this gene
cluster may contribute to pregnancy-related outcomes in chimpanzees that could be subject to natural
selective pressures.
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